Cite
MLA Citation
Lorinda Chung et al.. “Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial.” Lancet, vol. 2, 2020, pp. e743–e753. http://access.bl.uk/ark:/81055/vdc_100160110978.0x000001